A comparative study of cefaclor vs amoxicillin/clavulanate in pediatric pharyngotonsillitis

Medical Science Monitor

Volumn 9, Issue 3, 2003, Pages

  Haczyński, Józef ^a   Chmielik, Mieczysław ^a   Bień, Stanisław ^b   Kawalski, Henryk ^c   Zawadzka Głos, Lidia ^a   Mierzwa, Tadeusz ^b   Zyłka, Stanisław ^b   Moś, Mariusz ^c   Szendo Kita, Jolanta ^b   Mozejko Pastewka, Barbara ^a   Czarnocki, Krzysztof J ^d   Rek, Mirosław ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Regional District Hospital   (Poland)

^c Outpatient Clinic   (Poland)

^d LUBLIN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Drug efficacy; Drug safety; GABHS; Streptococcus pyogenes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFACLOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHARYNGITIS; RECURRENT INFECTION; RELAPSE; SINGLE BLIND PROCEDURE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; THROAT CULTURE; TONSILLITIS; TREATMENT OUTCOME; VOMITING;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CEFACLOR; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PHARYNGITIS; RECURRENCE; SAFETY; SINGLE-BLIND METHOD; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS;

EID: 0037353261     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. McMillan JA, Sandstrom C, Weiner LB et al: Viral and bacterial organisms associated with acute pharyngitis in a school-aged population, Journal of Pediatrics. 1986; 109(5): 747-52
2. Linder JA, Stafford RS: Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. JAMA, 2001; 286(10): 1181-1186
3. Pichichero ME: Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Annals of Emergency Medicine, 1995; 25(3): 390-403
4. Esposito S, De Ritis G, D'Errico G et al: Clinical comparison of Cefaclor twice daily versus amoxicillinŻclavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis. Clinical Therapeutics, 1998; 20(1): 72Ż79
5. Gerber MA, Tanz RR: New approaches to the treatment of group A streptococcal pharyngitis. Current Opinion in Pediatrics, 2001; 13(9): 51-55
6. Cooper RJ, Hoffman JR, Bartlett JG et al: Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Annals of Internal Medicine, 2001; 134(6): 309-517
7. Stillerman M: Comparison of oral cephalosporins with penicillin therapy For group A streptococcal pharyngitis. Pediatric Infectious Disease, 1986; 5(6): 649-54
8. Kaplan EL, Johnson DR: Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci front children with acute pharyngitis. Pediatrics, 2001; 108(5): 1180-6
9. Dajani AS: Current therapy of group A streptococcal pharyngitis. Pediatric Annals, 1998; 27(5): 277-280
10. Gerber MA, Tanz RR, Kabat W et al: Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics, 1999; 104(4 Pt 1): 911-7
11. Brook I: Penicillin failure and co-pathogenicity in streptococcal pharyngotonsillitis. Journal of Family Practice, 1994; 38(2): 175-179
12. Kim KS, Kaplan EL: Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. Journal of Pediatrics, 1985; 107(5): 681-684
13. Pichichero ME, Margolis PA: A comparison of cephalosporins and penicillin in the treatment of group A beta hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatric Infectious Disease Journal, 1991; 10(4): 275-281
14. Nyquist AC, Gonzales R, Steiner JF, Sande MA: Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA, 1998; 279(11): 875-877
15. Pichichero ME: Empiric antibiotic selection criteria for respiratory infections in pediatric practice. Pediatric Infectious Disease Journal, 1997; 16(Suppl. 3): 1-6
16. Klugman KP, Capper T, Widdowson CA et al: Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. Journal of Antimicrobial Chemotherapy, 1998; 42(6): 729-34
17. Syrogiannopoulos G, Grivea IN, Anastassiou ED et al: Sterile cerebrospinal fluid pleocytosis in young infants with urinary tract infecttion. Pediatric Infectious Disease Journal, 2001; 20(10): 927-930
18. Haczyński J, Bardadin J, Gryczyńska D et al: A comparative study of cefaclor vs. amoxicillin/clavulanate in tonsillopharyngitis. Medical Science Monitor, 2001; 7(5): 1016-1022
19. Derriennic M, Voi M, Thoren LM et al: Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis. Postgraduate Medical Journal, 1992; 68(3): 43-48
20. Holnt SE: Treatment of recurrent tonsillopharyngitis. Journal of Antimicrobial Chemotherapy. 2000; 45: 31-35
21. Pichichero ME, Casey JR, Mayes T et al: Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatric Infectious Disease Journal, 2000; 19(9): 917-923
22. Da̧browski MP, Stankiewicz W, Da̧browska-Bernstein BK: Wpływ antybiotyków na mechanizmy immunoregulacyjne ukladu odpornościowego. Medycyna po Dyplomie Wydanie Specjalne, Wrzesień, 1997: 1-12
23. Scheffer J, Knoeller J, Cullmann W, Konig W: Effects of cefamet and cefaclor on inflammatory responses of human granulocytes, basophiles and rat mastcells. Medecine et Maladies Infectieuses. 1992; 22: 548-555
24. Van Vlem B, Vanholder R, De Paepe P et al: Immunomodulating effects of antibiotics: literature review. Infection, 1996; 24(4): 275-291
25. Nord CE, Edlung C: Impact of antimicrobial agents on human intestinal microflora. Journal of Chemotherapy, 1990; 9(4): 218-237
26. Periti P: Rationale choice of an oral beta lactam antibiotic. Journal of Chemotherapy, 1997; 9(Suppl. 4): 1-3